Kyntra Bio Inc (KYNB)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2024 | 09-2024 | 06-2024 | 03-2024 | 12-2023 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 50,482 | 131,003 | 140,714 | 105,734 | 81,553 |
| Marketable Securities | N/A | N/A | N/A | 71,865 | 121,898 |
| Receivables | 481 | 29,030 | 6,412 | 37,083 | 5,121 |
| Inventories | 3,155 | 23,937 | 25,397 | 27,335 | 17,173 |
| Other current assets | 110,849 | 0 | 0 | 0 | 65,776 |
| TOTAL | $196,509 | $244,529 | $209,459 | $278,167 | $331,559 |
| Non-Current Assets | |||||
| PPE Net | N/A | 7,603 | 10,917 | 12,166 | 4,785 |
| Investments And Advances | 0 | 5,806 | 6,912 | 5,776 | 0 |
| Other Non-Current Assets | 18,016 | 6,483 | 65,915 | 69,759 | 87,185 |
| TOTAL | $18,016 | $19,892 | $83,744 | $87,701 | $91,970 |
| Total Assets | $214,525 | $264,421 | $293,203 | $365,868 | $423,529 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 5,064 | 9,238 | 9,938 | 4,353 | 15,778 |
| Accrued Expenses | 62,035 | 151,141 | 113,574 | 164,286 | 132,987 |
| Other current liabilities | 38,917 | N/A | N/A | N/A | 43,516 |
| TOTAL | $133,306 | $190,530 | $148,589 | $196,733 | $217,668 |
| Non-Current Liabilities | |||||
| Long Term Debt | 73,092 | 72,779 | 72,478 | 72,213 | 71,934 |
| Deferred Revenues | 27,290 | 28,858 | 9,546 | 12,863 | 12,740 |
| Other Non-Current Liabilities | 98,534 | 98,073 | 152,797 | 157,439 | 160,051 |
| TOTAL | $286,334 | $297,071 | $356,467 | $376,770 | $389,540 |
| Total Liabilities | $419,640 | $487,601 | $505,056 | $573,503 | $607,208 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 4,037 | 4,031 | 4,016 | 3,979 | 3,951 |
| Common Shares | 1,009 | 1,008 | 1,004 | 995 | 988 |
| Retained earnings | -1,889,499 | -1,907,481 | -1,890,397 | -1,874,853 | -1,841,920 |
| Other shareholders' equity | 14,755 | 14,859 | 16,678 | 13,980 | 13,612 |
| TOTAL | $-205,115 | $-223,180 | $-211,853 | $-207,635 | $-183,679 |
| Total Liabilities And Equity | $214,525 | $264,421 | $293,203 | $365,868 | $423,529 |